Medivir AB (OSTO:MVIR)
kr 2.87 0.08 (2.87%) Market Cap: 321.92 Mil Enterprise Value: 165.94 Mil PE Ratio: 0 PB Ratio: 2.27 GF Score: 53/100

Q2 2019 Medivir AB Earnings Call Transcript

Aug 28, 2019 / 12:00PM GMT
Release Date Price: kr16.15 (-1.64%)
Operator

Ladies and gentlemen, welcome to the Medivir Q2 Report 2019. Today, I am pleased to present Uli Hacksell, CEO; and Magnus Christensen, CFO. (Operator Instructions)

I will now hand you over to Uli Hacksell. Please begin.

Uli Hacksell;publ;CEO
Medivir AB;President & Director

()- -

Thank you, and good afternoon. I'm Uli Hacksell, and I'm joined by Magnus Christensen, our CFO; by Lotta Ferm, who is our previous Interim CFO, who will -- was in fact responsible for the financials in the second quarter. Also here is Linda Basse, our Chief Medical Officer.

And I will ask you to look at Slide #2 first because it has some important forward-looking statements, and I think it's important that you read that.

Now let me move to Slide 3 and ask Magnus to go through the financial summary.

Magnus Christensen;publ;CFO
Medivir AB

()-

Thank you, Uli. Hi, everyone. My name is Christensen here, CFO. If you look at Slide 3, you can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot